Eudaimonic well-being and tumor norepinephrine in patients with epithelial ovarian cancer

E-ISSN： 1097-0142|121|19|3543-3550

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.19, 2015-10, pp. : 3543-3550

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sedative effect of antipsychotics impairs patients' well-being

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 481, 2005-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Subjective Well-being of Patients with Schizophrenia as a Target of Drug Treatment

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. : 1490-1499

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted therapy for epithelial ovarian cancer

By Sharma Sameer Odunsi Kunle

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 501-513

Informa Healthcare

Access to resources Recommend Favorite

Beta-blockers in epithelial ovarian cancer

By Venniyoor Ajit

Cancer, Vol. 122, Iss. 1, 2016-01 ,pp. : 161-161

Blackwell Publishing

Access to resources Recommend Favorite

Increased elimination of paclitaxel by magnesium isoglycyrrhizinate in epithelial ovarian cancer patients treated with paclitaxel plus cisplatin: a pilot clinical study

By Chen Kai Chen Wan Chen Xia Jia Yi Peng Gui Chen Li

European Journal of Drug Metabolism and Pharmacokinetics, Vol. 39, Iss. 1, 2014-03 ,pp. : 25-31

Springer Publishing Company

Access to resources Recommend Favorite